Silencing GATA2 leads to inhibition of the enzalutamide-induced genes NR3C1 and SLC7A11. Consistent with these findings, the GATA2 inhibitor K7174 impaired the growth of PCa cells in response to enzalutamide. The gene discussed is GATA2; the disease is posterior cortical atrophy.